Cancer cell proliferation increased in OTME-Chips relative to controls during 40 to 72 hours of extravasated platelets and tumor interaction, and proliferation was found diminished in galectin-3 KO–OTME-Chips (Fig. 3D). This evidence concerns the gene LGALS3 and cancer.